1,235 Intuitive Surgical, Inc. $ISRG Shares Purchased by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 123.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,237 shares of the medical equipment provider’s stock after purchasing an additional 1,235 shares during the period. CHICAGO TRUST Co NA’s holdings in Intuitive Surgical were worth $910,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. North Point Portfolio Managers Corp OH acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. John Boyer Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $27,000. Compass Wealth Management LLC acquired a new stake in Intuitive Surgical during the third quarter worth about $29,000. Main Street Group LTD acquired a new stake in Intuitive Surgical during the first quarter worth about $30,000. Finally, Compass Financial Management LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 3.7%

Shares of Intuitive Surgical stock opened at $432.01 on Friday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The business has a fifty day simple moving average of $401.54 and a 200-day simple moving average of $434.05. The stock has a market cap of $149.75 billion, a PE ratio of 52.24, a price-to-earnings-growth ratio of 2.98 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the company earned $2.40 EPS. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ISRG. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research report on Wednesday, October 21st. Citigroup dropped their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Oppenheimer restated an “outperform” rating and set a $500.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 21st. Finally, Barclays reissued an “overweight” rating and issued a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $493.54.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of the firm’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the transaction, the director directly owned 1,150 shares in the company, valued at $510,370. This trade represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 20,095 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. The trade was a 1.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 38,778 shares of company stock worth $16,814,967 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.